{"entity":{"type":"insider","cik":"0001318005","url":"/insider/0001318005","json_url":"/insider/0001318005.json","name":"Aguiar Michael W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2010-12-03","last":"2017-12-05","span_basis":"filed_date"},"name_variants":[{"name":"Aguiar Michael W","source":"filing","n_filings":8,"first_seen":"2010-12-03","last_seen":"2017-12-05"}],"transactions":[{"id":5057874,"accession":"0001179110-17-014945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-014945","line_url":"/filing/0001179110-17-014945#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"Innoviva, Inc.","issuer_ticker":"INVA","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Director, Officer (President & Chief Exec Officer)","officer_title":"President & Chief Exec Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12022.0,"shares_display":"12,022","price_per_share":13.1252,"price_display":"13.13","price_state":"stated","total_value":157791.1544,"total_display":"157,791.15","shares_owned_after":980907.0,"shares_owned_after_display":"980,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-05","scope":"insider"},{"id":5017781,"accession":"0001179110-13-007589","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-007589","line_url":"/filing/0001179110-13-007589#line-3","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160779.0,"shares_display":"160,779","price_per_share":33.77,"price_display":"33.77","price_state":"stated","total_value":5429506.83,"total_display":"5,429,506.83","shares_owned_after":152586.0,"shares_owned_after_display":"152,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-02","scope":"insider"},{"id":5017772,"accession":"0001179110-13-007589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-007589","line_url":"/filing/0001179110-13-007589#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10100.0,"shares_display":"10,100","price_per_share":34.34,"price_display":"34.34","price_state":"stated","total_value":346834.0,"total_display":"346,834.00","shares_owned_after":142486.0,"shares_owned_after_display":"142,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-02","scope":"insider"},{"id":3046704,"accession":"0001179110-12-013430","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-12-013430","line_url":"/filing/0001179110-12-013430#line-4","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17700.0,"shares_display":"17,700","price_per_share":27.24,"price_display":"27.24","price_state":"stated","total_value":482148.0,"total_display":"482,148.00","shares_owned_after":135347.0,"shares_owned_after_display":"135,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-27","filed_date":"2012-08-28","scope":"insider"},{"id":3046701,"accession":"0001179110-12-013430","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-12-013430","line_url":"/filing/0001179110-12-013430#line-3","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2861.0,"shares_display":"2,861","price_per_share":27.86,"price_display":"27.86","price_state":"stated","total_value":79707.46,"total_display":"79,707.46","shares_owned_after":132486.0,"shares_owned_after_display":"132,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-27","filed_date":"2012-08-28","scope":"insider"},{"id":3046696,"accession":"0001179110-12-013430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-12-013430","line_url":"/filing/0001179110-12-013430#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4121.0,"shares_display":"4,121","price_per_share":28.01,"price_display":"28.01","price_state":"stated","total_value":115429.21,"total_display":"115,429.21","shares_owned_after":153047.0,"shares_owned_after_display":"153,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-24","filed_date":"2012-08-28","scope":"insider"},{"id":3538247,"accession":"0001179110-12-012652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-12-012652","line_url":"/filing/0001179110-12-012652#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":27.04,"price_display":"27.04","price_state":"stated","total_value":1622400.0,"total_display":"1,622,400.00","shares_owned_after":157924.0,"shares_owned_after_display":"157,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-07","filed_date":"2012-08-09","scope":"insider"},{"id":3371592,"accession":"0001179110-12-009400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-009400","line_url":"/filing/0001179110-12-009400#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.29,"price_display":"22.29","price_state":"stated","total_value":445800.0,"total_display":"445,800.00","shares_owned_after":157924.0,"shares_owned_after_display":"157,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-31","scope":"insider"},{"id":9014365,"accession":"0001179110-11-016563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-016563","line_url":"/filing/0001179110-11-016563#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.86,"price_display":"21.86","price_state":"stated","total_value":218600.0,"total_display":"218,600.00","shares_owned_after":186774.0,"shares_owned_after_display":"186,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-09","filed_date":"2011-12-13","scope":"insider"},{"id":9147212,"accession":"0001179110-11-009799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-009799","line_url":"/filing/0001179110-11-009799#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14225.0,"shares_display":"14,225","price_per_share":22.94,"price_display":"22.94","price_state":"stated","total_value":326321.5,"total_display":"326,321.50","shares_owned_after":201838.0,"shares_owned_after_display":"201,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-14","filed_date":"2011-06-16","scope":"insider"},{"id":7705365,"accession":"0001179110-10-016949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-016949","line_url":"/filing/0001179110-10-016949#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001318005","owner_name":"Aguiar Michael W","owner_url":"/insider/0001318005","role":"Officer (Sr VP, Chief Financial Officer)","officer_title":"Sr VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.51,"price_display":"26.51","price_state":"stated","total_value":265100.0,"total_display":"265,100.00","shares_owned_after":109601.0,"shares_owned_after_display":"109,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-03","filed_date":"2010-12-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"Innoviva, Inc.","url":"/issuer/0001080014","role":"Director, Officer (President & Chief Exec Officer)","n_filings":8,"first_seen":"2010-12-03","last_seen":"2017-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001318005","retrieved_at":"2026-08-21T18:21:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}